JP2022542699A5 - - Google Patents

Info

Publication number
JP2022542699A5
JP2022542699A5 JP2022506413A JP2022506413A JP2022542699A5 JP 2022542699 A5 JP2022542699 A5 JP 2022542699A5 JP 2022506413 A JP2022506413 A JP 2022506413A JP 2022506413 A JP2022506413 A JP 2022506413A JP 2022542699 A5 JP2022542699 A5 JP 2022542699A5
Authority
JP
Japan
Prior art keywords
seq
antibody
fragment
sequence
antibody fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022506413A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022542699A (ja
JP7667773B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/043908 external-priority patent/WO2021021830A1/en
Publication of JP2022542699A publication Critical patent/JP2022542699A/ja
Publication of JP2022542699A5 publication Critical patent/JP2022542699A5/ja
Application granted granted Critical
Publication of JP7667773B2 publication Critical patent/JP7667773B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022506413A 2019-07-29 2020-07-28 カンジダ属に対する抗体およびその使用法 Active JP7667773B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962879894P 2019-07-29 2019-07-29
US201962879912P 2019-07-29 2019-07-29
US62/879,912 2019-07-29
US62/879,894 2019-07-29
PCT/US2020/043908 WO2021021830A1 (en) 2019-07-29 2020-07-28 Antibodies to candida and uses thereof

Publications (3)

Publication Number Publication Date
JP2022542699A JP2022542699A (ja) 2022-10-06
JP2022542699A5 true JP2022542699A5 (enExample) 2023-06-20
JP7667773B2 JP7667773B2 (ja) 2025-04-23

Family

ID=74230808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506413A Active JP7667773B2 (ja) 2019-07-29 2020-07-28 カンジダ属に対する抗体およびその使用法

Country Status (8)

Country Link
US (1) US20220280618A1 (enExample)
EP (1) EP4007772A4 (enExample)
JP (1) JP7667773B2 (enExample)
KR (1) KR102822827B1 (enExample)
CN (1) CN114901688A (enExample)
AU (1) AU2020323925A1 (enExample)
CA (1) CA3146123A1 (enExample)
WO (1) WO2021021830A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115991752B (zh) * 2022-12-07 2025-10-31 中国科学技术大学 特定组氨酸甲基化修饰的pra1蛋白免疫原、多克隆抗体及应用
WO2025090760A1 (en) * 2023-10-25 2025-05-01 Board Of Regents, The University Of Texas System Antibodies specific to scube3 and methods of use
CN119930808B (zh) * 2025-01-09 2025-11-25 普健生物（武汉）科技有限公司 一种抗白念珠菌Csa2蛋白的单克隆抗体及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2651575B2 (ja) * 1987-07-13 1997-09-10 神鋼電機株式会社 インバータの過電流検出装置
EP1169352A4 (en) * 1999-04-14 2005-05-04 Smithkline Beecham Corp ANTIBODY AGAINST THE ERYTHROPOIETIN RECEPTOR
US20080148432A1 (en) * 2005-12-21 2008-06-19 Mark Scott Abad Transgenic plants with enhanced agronomic traits
GB0505489D0 (en) * 2005-03-18 2005-04-20 Domantis Ltd Antibodies
EP2102244A2 (en) * 2006-12-19 2009-09-23 Ablynx N.V. Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
WO2011035205A2 (en) * 2009-09-18 2011-03-24 Calmune Corporation Antibodies against candida, collections thereof and methods of use
JP2014515757A (ja) 2011-04-21 2014-07-03 ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティ アンド アグリカルチュラル アンド メカニカル カレッジ 真菌感染症のペプチド及び結合型ワクチン
US10590178B2 (en) * 2014-06-25 2020-03-17 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Chimeric vaccine against fungal infections
WO2016155652A1 (en) * 2015-04-01 2016-10-06 Sy-Jye Leu Antibodies against infectious diseases
IL256562B2 (en) * 2015-07-15 2024-07-01 Genmab As Human CD3 antibodies or chimeras
WO2018237010A2 (en) * 2017-06-20 2018-12-27 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Vaccine compositions and methods of using the same

Similar Documents

Publication Publication Date Title
JP2022541652A5 (enExample)
JP2023518849A5 (enExample)
JP2022542699A5 (enExample)
EP2087004A2 (en) A novel passive vaccine for candida infections
JP2022513075A5 (enExample)
JP7288927B2 (ja) 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用
CN110624107A (zh) 通过施用il-4r拮抗剂治疗或预防哮喘的方法
CN111615519B (zh) 结合人il-5的单克隆抗体、其制备方法和用途
JP2021518390A5 (enExample)
JP2022515480A (ja) 掌蹠膿疱症の処置のための抗ｉｌ－３６ｒ抗体
US20190194311A1 (en) Methods of treating new-onset plaque type psoriasis using il-17 antagonists
JP2021518415A5 (enExample)
WO2021249445A1 (zh) 抗il-17a抗体药物组合物及其用途
JP2025507595A5 (enExample)
JPWO2022044573A5 (enExample)
CN114605539A (zh) 人源化的抗IL-4Rα单域抗体及其应用
CN109206515B (zh) 一种全人源抗人白介素17a抗体及其应用
RU2689326C1 (ru) Антиретровирусное лекарственное средство, нацеленное на эндогенный ретровирус человека
JP2022530063A (ja) 抗体製剤
JP2023502387A5 (enExample)
CN113549146B (zh) 针对柯萨奇病毒b1型的单克隆抗体及其用途
JP7171913B2 (ja) 化膿性汗腺炎の治療のための汎ｅｌｒ＋ｃｘｃケモカイン抗体
JP2020518604A (ja) Ｉｌ−１７アンタゴニストを使用して喘息を選択的に治療する方法
WO2021214758A1 (en) Ccl24 inhibitors in the treatment of covid-19
CN115260306A (zh) 靶向SARS-CoV-2受体结合基序的单克隆抗体及其识别抗原表位和应用